Covidien Introduces `Trusted Hands`
* Reuters is not responsible for the content in this press release.
Product Innovation MessagingHighlights Customers` Confidence BOULDER, Colo.--(Business Wire)-- Covidien (NYSE: COV, BSX: COV), a world leader in advanced energy-based surgical systems, today announced that its Energy-based Devices (EbD) business unit is launching Trusted Hands, a new, broad-based marketing approach that highlights EbD`s innovative products and the confidence they have long inspired in customers. For more than 40 years, surgeons have relied on EbD products when performing vital clinical procedures that ultimately enhance the quality of life for patients. The Trusted Hands message focuses on this demonstrated customer confidence in EbD`s technological innovation and superior product quality. The Trusted Hands message, which will be communicated via print, multimedia and electronic media globally, will focus on the core values and needs of customers - surgeons, nurses, hospital administrators and biomedical engineers. The message will show how EbD provides solutions that address the needs and concerns of medical practitioners. "We`ve learned from our customers that trust is what matters most. Trust is a message that genuinely resonates with surgeons and other healthcare providers," said Cameron Rouns, Vice President of Global Marketing for Covidien EbD. "Surgeons have told us that in Trusted Hands, we address the most meaningful elements of their day-to-day concerns as medical practitioners. Our message reflects Covidien`s commitment to providing products and technologies that improve outcomes and enhance the quality of life for patients." Trusted Hands will focus first on the LigaSure system, which has been used successfully in nearly four million procedures. LigaSure technology is supported by more than 200 published peer-reviewed studies in leading medical journals around the world. LigaSure instruments are designed to work with the ForceTriad energy platform. The energy system features TissueFect sensing technology - a proprietary, software-driven control system that provides feedback on the energy-tissue relationship more than 3,000 times per second and continually adjusts output and energy delivery. The result is consistent and reliable vessel sealing delivered by a highly efficient energy-based platform, which is today used in thousands of hospitals and surgical centers globally. "This is the first time we`ve reached out to our customers on this kind of scale," said Bryan Hanson, President of Covidien EbD. "We are proud to be leaders in our market segment, and we expect that the new Trusted Hands messaging will help drive our continued strong growth in the electrosurgery industry." ABOUT COVIDIEN Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2008 revenue of nearly $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business. Covidien Sherri Hughes-Smith, 303-581-6849 Manager, Media and Public Relations Energy-based Devices sherri.hughes-smith@covidien.com or Bruce Farmer, 508-452-4372 Vice President Public Relations bruce.farmer@covidien.com or Coleman Lannum, CFA, 508-452-4343 Vice President Investor Relations cole.lannum@covidien.com or Wayde McMillan, 508-452-4387 Director Investor Relations wayde.mcmillan@covidien.com Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters